Cited by 361Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration MechanismsNeurological diseases and metabolism

Multiple organ involvement by alpha-synuclein pathology in lewy body disorders

Gelpi, Ellen, Navarro‐Otano, Judith, Tolosa, Eduardo, Gaig, Carles, Compta, Yaroslau, Rey, María Jesús, Martí, Maria José, Hernández, Isabel +3 more·2014·Movement Disorders

Abstract

Lewy body (LB) diseases are characterized by alpha-synuclein (AS) aggregates in the central nervous system (CNS). Involvement of the peripheral autonomic nervous system (pANS) is increasingly recognized, although less studied. The aim of this study was to systematically analyze the distribution and severity of AS pathology in the CNS and pANS. Detailed postmortem histopathological study of brain and peripheral tissues from 28 brain bank donors (10 with Parkinson's disease [PD], 5 with dementia with LB [DLB], and 13 with non-LB diseases including atypical parkinsonism and non-LB dementia). AS aggregates were found in the pANS of all 15 LB disease cases (PD, DLB) in stellate and sympathetic ganglia (100%), vagus nerve (86.7%), gastrointestinal tract (86.7%), adrenal gland and/or surrounding fat (53.3%), heart (100%), and genitourinary tract (13.3%), as well as in 1 case of incidental Lewy body disease (iLBD). A craniocaudal gradient of AS burden in sympathetic chain and gastrointestinal tract was observed. DLB cases showed higher amounts of CNS AS aggregates than PD cases, but this was not the case in the pANS. No pANS AS aggregates were detected in Alzheimer's disease (AD) cases with or without CNS AS aggregates. All pathologically confirmed LB disease cases including 1 case of iLBD had AS aggregates in the pANS with a craniocaudal gradient of pathology burden in sympathetic chain and gastrointestinal tract. AS was not detected in the pANS of any AD case. These findings may help in the search of peripheral AS aggregates in vivo for the early diagnosis of PD.

Integrity signals

Registry

Crossref · 10.1002/mds.25776

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several clinical studies revealed that Parkinson's disease patients expressed alpha-synuclein accumulation in the enteric nervous system.

    “Several clinical studies revealed that PD patients expressed alphasynuclein accumulation in the ENS (Braak et al., 2006;Forsyth et al., 2011;Gelpi et al., 2014;Gold et al., 2013;Sánchez-Ferro et al., 2015;Shannon et al., 2012a).”

The citation lists haven’t been fetched yet

References 34 · Cited by 361

Authors
Gelpi, E., Navarro‐Otano, J., Tolosa, E., Gaig, C., Compta, Y., Rey, M. J., Martí, M. J., Hernández, I., Valldeoriola, F., Reñé, R., & Ribalta, T.
Affiliations
  • Neurological Tissue Bank of the Biobanc‐Hospital Clinic‐Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain
  • Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
  • Hospital Clínic de Barcelona (ES)
  • Parkinson's Disease and Movement Disorders Unit Institut Clínic de Neurociències, Hospital Clinic de Barcelona Barcelona Spain
  • Fundació ACE (ES)
  • Department of Neurology University Hospital of Bellvitge Barcelona Spain
Corresponding author
Tolosa, Eduardo
Venue
Movement Disorders
Publisher
Wiley
Published
2014-01-02
Volume
29
Issue
8
Pages
1010-1018
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W2104950937
Cited by
361
References
34
Citations by year
2026: 11 · 2025: 20 · 2024: 25 · 2023: 29 · 2022: 39 · 2021: 48 · 2020: 32 · 2019: 34 · 2018: 25 · 2017: 33 · 2016: 37 · 2015: 18 · 2014: 9
FWCI
21.09
Type
journal article
Language
en
Open access
closed
Locations
  • Movement Disorders (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
alpha-synuclein, Lewy body disease, Parkinson's disease, dementia with Lewy bodies, incidental Lewy body disease, peripheral autonomic nervous system, alpha-synuclein aggregates, sympathetic ganglia, gastrointestinal tract, vagus nerve, Alzheimer's disease, postmortem neuropathology
MeSH terms
Adrenal Glands, Aged, Aged, 80 and over, Autonomic Nervous System, Central Nervous System, Female, Humans, Male, Myocardium, Retrospective Studies, Urogenital System, Lewy Body Disease, Gastrointestinal Tract, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review